论文部分内容阅读
目的:探究分析糖尿病达标管理在改善2型糖尿病(T2DM)患者低密度脂蛋白胆固醇(LDL-C)的效果。方法:选取本院2012年2月-2013年3月收治的102例T2DM患者,采用分阶段糖尿病达标管理模式,对患者行“开始、调整、维持”3个阶段综合管理,随访患者管理后第1年及第2年的LDC-C值的监测数值和监测频率,并对百分比和均数进行对比。结果:经分阶段糖尿病达标管理后,患者的各项指标达标率均呈上升趋势,管前后指标达标率对比,差异具有统计学意义(P<0.05)。随访管理后第1年和第2年LDL-C监测频率由20.6%分别上升至74.5%和91.2%,组间比较,差异具有统计学意义(P<0.05),与基线相比随访1年后的LDL-C值明显降低,2年后LDL-C值进一步降低,组间比较,差异具有统计学意义(P<0.05)。结论:2年内对2型糖尿病患者采用分阶段糖尿病达标管理,患者的LDL-C值呈下降趋势,而患者LDL-C值的监测频率呈上升趋势,管理后第2年效果更加明显。
Objective: To investigate the effect of diabetes compliance management on improving low density lipoprotein cholesterol (LDL-C) in patients with type 2 diabetes mellitus (T2DM). Methods: A total of 102 patients with T2DM admitted from February 2012 to March 2013 in our hospital were enrolled in this study. The patients were treated with “Start, Adjust and Maintain” Monitoring values and monitoring frequency of LDC-C values in the first year and the second year were compared, and the percentage and the mean were compared. Results: After the management of staged diabetes, the compliance rates of all the indexes showed an upward trend, and the compliance rate of indicators before and after the control was statistically significant (P <0.05). The monitoring frequency of LDL-C increased from 20.6% to 74.5% and 91.2% in the first year and the second year after follow-up management, respectively. There was significant difference between the two groups (P <0.05) LDL-C decreased significantly, and LDL-C decreased further after 2 years. The difference between the two groups was statistically significant (P <0.05). CONCLUSIONS: Patients with type 2 diabetes mellitus receive standard management of diabetes mellitus within 2 years. The LDL-C value of patients with type 2 diabetes is on a downward trend. However, the monitoring frequency of LDL-C is on the rise.